The Alliance for Safe Biologic Medicines and Pennsylvania Bio hosted an event entitled, “Biosimilars Policy Forum: Ensuring Patient Safety” in Philadelphia, PA, on August 17, 2011

The purpose of the forum discussion was to explore with community members, including policymakers, patients, physicians, pharmacists, and hospital officials the importance of maintaining patient safety as the U.S. Food and Drug Administration’s top priority while it works to establish an approval pathway for biosimilar products.

Participants in the Forum included:

Stephen Tang, PhD, University City Science Center
Richard Dolinar, MD, Alliance for Safe Biologic Medicines
Christopher Molineaux, Pennsylvania Bio
Seth Ginsberg, Global Healthy Living Foundation
Philip Gerbino, PharmD, University of the Sciences in Philadelphia
Andrew Spiegel, Colon Cancer Alliance

Photographs of the forum are available below.